Barriera Therapeutics (BTX) Revenue

Biotechnology Research • • 1-10 Employees

Barriera Therapeutics (BTX) revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Barriera Therapeutics (BTX)

Joppe Nieuwenhuis

Co-Founder

Company overview

Headquarters	XX
NAICS	541714
Employees	1-10

About Barriera Therapeutics (BTX)

BTX is a preclinical-stage biotech company developing therapies that restore the body’s natural protective barriers. Our lead program targets kidney disease by repairing the glomerular filtration barrier in Alport syndrome. We combine deep biological insight with lean, CRO-driven development to rapidly validate targets and accelerate path-to-clinic.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Barriera Therapeutics (BTX) has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Barriera Therapeutics (BTX) has never raised funding before.

Frequently asked questions

Barriera Therapeutics (BTX) is located in XX.

Barriera Therapeutics (BTX) generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Barriera Therapeutics (BTX) has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Barriera Therapeutics (BTX) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Barriera Therapeutics (BTX)

Joppe Nieuwenhuis

Co-Founder

4.8

40,000 users